PYX Resources: Achieving volume and diversification milestones. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Hi, I see you on some of the shares I hold or am looking at and wondered if you would do me the favour of telling me what you have in your p/f. I am trying to move away from some of my riskier ones to larger caps and was interested as to what you may hold. Cheers
Synergy Health (SYR) posted a 17.3% jump in adjusted pre-tax profit for its full-year, with good underlying growth in each of its regions, and said it anticipated a similarly strong performance in the new financial year. The healthcare outsourcing firm reported an adjusted pre-tax profit of 38.3 million pounds for the 12-months ended 3rd April 2011 on operating margins up 1.1% to 15%. Shares in Synergy, which is the UK's largest provider of decontamination and sterile services for surgical instruments, advanced 41.5p to 921.5p
Richard Steeves, Chief Executive of Synergy Health, said: "Overall Synergy is in good shape with an internationally diversified business providing high value added services on long term contracts, and a forward order book of nearly £1 billion." "Our services are mission-critical to our customers, and for this reason the demand for outsourcing is growing. Looking ahead, we expect that rising regulatory and technical standards will continue to underpin demand." "We expect to see the Group's overall revenue growth rates reach double digits over the next twelve to eighteen months. Higher revenue growth rates, supported by sustainable improved margins and strong cash generation, leave the business well positioned to continue to deliver its earnings objectives. The new financial year has started strongly." *Note: Adjusted profit before tax and Adjusted earnings per share exclude amortisation of acquired intangibles and non-recurring items, as shown in the Group's consolidated income statement and the accompanying notes.
Outlook · Focusing on the international development of sterilisation services is lifting growth rates · UK austerity measures are not impacting growth in core services · Acquisitions integrated and performing ahead of expectations · Strong start to new financial year and the Board looks forward to another positive year
Operational Highlights · Acquisitions of GSP and, post period end, BeamOne, positioned Synergy as the second largest global provider of outsourced sterilisation services · New EtO facility in Venlo operating at capacity and expansion programme underway · New Gamma facility under construction at Marcoule · c.£1.8 million p.a. of new medical device sterilisation contracts won in China, which will lead to further expansion · c.£10 million of new hospital sterilisation contracts won during the year · New hospital sterilisation facility opened in February 2011, serving three hospitals in Leicester · Three further UK hospital sterilisation facilities scheduled to open in current financial year · Suzhou, China facility now handling hospital sterilisation work for 30 customers
Financial Highlights · Underlying revenues up 4.1% before currency effects and closure of non-core businesses · Adjusted* operating profit margin up by 1.1% to 15.0% (2010: 13.9%) · Cash generated from operations increased 9.5% to £83.7 million (2010: £76.5 million) · Net debt reduced by £21.1 million to £112.3 million · Forward order book increased 8.2% to £920 million (2010: £850 million)
http://investegate.co.uk/Article.aspx?id=201106070700119584H
This should rise now before the release of the results.
Following a third-quarter interim management statement, Singer Capital Markets retained its "fair value recommendation on Synergy Health (SYR), the decontamination and sterile services provider, with a 839p target price. The broker thinks the group is a fundamentally sound, well-run business with an attractive outlook. It continues to believe that the outlook of the firm is improving and that, from financial year 2013, investors will start to see the benefits of the move into China and the current attractive bid book. That said, Singer currently sees the shares as fairly valued but thinks that any weakness in the share price would be an attractive opportunity for investors. Shares in Synergy inched ahead 6.5p to 891p.
Due out tomorrow. What makes you think that someone, somewhere, for some reason (of course, without inside information) is expecting them to be good? 6.55% rise today. Perhaps they are just gambling on them being good?
What is the future for these ? they are my best performers since I started getting into shares in January...would hate to see my profits disappear...!
I want to get a last-year financial report of synergy.Who can give me a favor?Thank you in advance. Pls send it to my E-mail(gujun9989@hotmail.com). Thank you very much.
Anybody got a view on these at £371.25, Investors Chronicle rate them a buy at £4.68 this week.